This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ortíz, M. C. Articles by García-Estañ, J. Search for Related Content PubMed PubMed Citation Articles by Ortíz, M. C. Articles by García-Estañ, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-ARGININE NITRIC OXIDE

(Hypertension. 1996;27:377-381.)
© 1996 American Heart Association, Inc.

Articles

Importance of Nitric Oxide and Prostaglandins in the Control of Rat Renal Papillary Blood Flow

M. Clara Ortíz; Noemí M. Atucha; Vicente Lahera; Félix Vargas; Tomás Quesada; Joaquín García-Estañ

From the Departamento de Fisiología, Facultad de Medicina de Murcia (M.C.O., N.M.A., T.Q., J.G.-E.), Madrid (V.L.), and Granada (F.V.), Spain.

Correspondence to Joaquín García-Estañ, Departamento Fisiología, Facultad de Medicina, 30100 Murcia, Spain. E-mail jgel@fcu.um.es.

Abstract The role of nitric oxide and prostaglandins in the control of rat renal papillary blood flow has been studied in anesthetized Munich-Wistar rats by use of laser Doppler flowmeter. Acute administration of N-nitro-L-arginine methyl ester (L-NAME) 10 mg/kg IV (n=8) increased mean arterial pressure by 27.8±3.6%, decreased papillary blood flow by 39.4±3.8%, and decreased renal blood flow by 47.4±1.9%. The subsequent administration of indomethacin (7.5 mg/kg IV) further decreased papillary blood flow (35.2±2.5%) without significant changes in mean arterial pressure or renal blood flow. In a second group (n=6), administration of indomethacin before L-NAME decreased papillary blood flow by 39.6±2.1% without significantly altering mean arterial pressure or renal blood flow. The subsequent injection of L-NAME further decreased papillary blood flow (32.9±1.8%) and renal blood flow (49.8±6.6%) while increasing mean arterial pressure to a level not significantly different from that found in the first group. Autoregulation studies showed that L-NAME but not indomethacin reduced the renal perfusion pressure–renal blood flow relationship without altering autoregulation. However, both nitric oxide and prostaglandins importantly affected the renal perfusion pressure–papillary blood flow relationship because L-NAME and indomethacin significantly decreased this relationship in an additive fashion. Although both drugs reduced the sensitivity of the pressure–papillary flow relationship, only L-NAME affected autoregulation so that papillary blood flow was autoregulated at higher renal perfusion pressures. Thus, the present results indicate that both nitric oxide and prostaglandins control a similar percentage of rat renal papillary blood flow, but nitric oxide seems to be more important than prostaglandins as a mediator of the pressure–blood flow relationship. In contrast, only nitric oxide modifies the renal blood flow level, although it does not disturb whole-kidney blood flow autoregulation.

Key Words: kidney • hypertension, arterial • renal circulation • homeostasis • nitric oxide • prostaglandins

This article has been cited by other articles:

				S. Knight and E. J. Johns Effect of COX inhibitors and NO on renal hemodynamics following ischemia-reperfusion injury in normotensive and hypertensive rats Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1072 - F1077. [Abstract] [Full Text] [PDF]

				A. Sarkis, K. L. Liu, M. Lo, and D. Benzoni Angiotensin II and renal medullary blood flow in Lyon rats Am J Physiol Renal Physiol, February 1, 2003; 284(2): F365 - F372. [Abstract] [Full Text] [PDF]

				S. A. W. Dukacz, M.-G. Feng, L.-F. Yang, R. M. K. W. Lee, and R. L. Kline Abnormal renal medullary response to angiotensin II in SHR is corrected by long-term enalapril treatment Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1076 - R1084. [Abstract] [Full Text] [PDF]

				A.-P. Zou and A. W. Cowley Jr. alpha 2-Adrenergic receptor-mediated increase in NO production buffers renal medullary vasoconstriction Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2000; 279(3): R769 - R777. [Abstract] [Full Text] [PDF]

				E. TURKSTRA, B. BRAAM, and H. A. KOOMANS Impaired Renal Blood Flow Autoregulation in Two-Kidney, One-Clip Hypertensive Rats Is Caused by Enhanced Activity of Nitric Oxide J. Am. Soc. Nephrol., May 1, 2000; 11(5): 847 - 855. [Abstract] [Full Text]

				B. Braam Renal endothelial and macula densa NOS: integrated response to changes in extracellular fluid volume Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1551 - R1561. [Abstract] [Full Text] [PDF]

				B. Nafz, K. Berger, C. Rosler, and P. B. Persson Kinins modulate the sodium-dependent autoregulation of renal medullary blood flow Cardiovasc Res, December 1, 1998; 40(3): 573 - 579. [Abstract] [Full Text] [PDF]

				M. C. Ortiz, L. A. Fortepiani, F. M. Ruiz-Marcos, N. M. Atucha, and J. Garcia-Estan Role of AT1 receptors in the renal papillary effects of acute and chronic nitric oxide inhibition Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R760 - R766. [Abstract] [Full Text] [PDF]

				A.-P. Zou, F. Wu, and A. W. Cowley Jr Protective Effect of Angiotensin II-Induced Increase in Nitric Oxide in the Renal Medullary Circulation Hypertension, January 1, 1998; 31(1): 271 - 276. [Abstract] [Full Text] [PDF]